The Hungarian pharmaceutical company Gedeon Richter Plc. - together with Sumitomo Pharma America, Inc. and Sumitomo Pharma Switzerland, GmbH - has announced on the website of the Budapest Stock Exchange that the European Commission has granted approval of a Type II Variation application for RYEQO® (relugolix 40 mg, estradiol 1.0 mg, and norethisterone acetate 0.5 […]

Hungarian phrama company Gedeon Richter Plc. has announced that it has submitted a Type II Variation application for RYEQO® to the European Medicines Agency (EMA) for the treatment of moderate to severe pain associated with endometriosis in adult women of reproductive age with a history of previous medical or surgical treatment for their endometriosis. RYEQO® […]